Magnetic Resonance Deep Learning Radiomic Model Based on Distinct Metastatic Vascular Patterns for Evaluating
Cheng Zhang1, Li-di Ma1, Xiao-Lan Zhang2
1Department of Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Journal of Magnetic Resonance Imaging : JMRI
|October 27, 2023
Summary
A new deep learning model incorporating vascular patterns like VETC and MVI shows promise for predicting recurrence-free survival in hepatocellular carcinoma (HCC) patients after resection.
Area of Science:
- Hepatobiliary Malignancies
- Medical Imaging
- Machine Learning in Oncology
Background:
- Hepatocellular carcinoma (HCC) metastasis involves microvascular invasion (MVI) and vessels encapsulating tumor clusters (VETC).
- Existing radiological studies primarily focus on predicting VETC status, with less emphasis on its combined prognostic value with MVI.
Purpose of the Study:
- To develop and compare predictive models for recurrence-free survival (RFS) in HCC patients.
- To evaluate clinical, radiomics, and deep learning models incorporating VETC and MVI for RFS prediction.
Main Methods:
- Retrospective analysis of 398 HCC patients undergoing resection, divided into training (n=358) and testing (n=40) cohorts.
- Development of clinical, radiomics, and deep learning models using MRI data (T1WI, T2WI, contrast-enhanced phases) and clinical factors (VETC, MVI, Barcelona stage, tumor diameter, AFP).
- Statistical analysis included COX regression, LASSO, Kaplan-Meier curves, and C-index for model performance evaluation.
Main Results:
- The deep learning model achieved the highest predictive performance with a C-index of 0.830 in the test cohort.
- Performance comparison showed the deep learning model outperformed the clinical-radiomic nomogram (0.731), radiomic signature (0.707), and clinical model (0.702).
- The average RFS for all patients was 26.77 months.
Conclusions:
- A magnetic resonance (MR) deep learning model integrating VETC and MVI offers a valuable tool for assessing survival outcomes in HCC patients.
- This approach has the potential to improve prognostic accuracy and guide clinical decision-making for HCC management.


